Do Antiplatelet Drugs Use Contribute to Clinical Outcomes in Patients Receiving Penile Low- Intensity Shock Wave Therapy (Li-SWT) for Erectile Dysfunction?

Geyik, Serdar; Değer, Mutlu; Akdoğan, Nebil; Kankılıç, Nazım; Yılmaz, İsmail Önder; Arıdoğan, İbrahim Atilla

Do Antiplatelet Drugs Use Contribute to Clinical Outcomes in Patients Receiving Penile Low- Intensity Shock Wave Therapy (Li-SWT) for Erectile Dysfunction?

dc.authorid	0000-0002-8357-5744
dc.authorid	0000-0001-9756-8775
dc.authorid	0000-0002-3747-3798
dc.authorid	0000-0003-2325-177X
dc.authorid	0000-0002-3805-7817
dc.contributor.author	Geyik, Serdar
dc.contributor.author	Değer, Mutlu
dc.contributor.author	Akdoğan, Nebil
dc.contributor.author	Kankılıç, Nazım
dc.contributor.author	Yılmaz, İsmail Önder
dc.contributor.author	Arıdoğan, İbrahim Atilla
dc.date.accessioned	2024-03-20T12:01:34Z
dc.date.available	2024-03-20T12:01:34Z
dc.date.issued	2023
dc.department	Tıp Fakültesi
dc.description.abstract	Low-intensity extracorporeal shock wave therapy (Li-SWT) is one of the recommended treatment options in patients with erectile dysfunction (ED). Li-SWT is safe in patients using antiplatelet drugs (APs), however, there are no specific studies on the contribution of APs use to clinical improvement in erectile function. We aimed to evaluate the early clinical results of Li-SWT administration and whether the use of APs had an additional positive contribution to clinical improvement and safe in ED patients. Methods: Patients with ED for more than 6 months despite using (5 mg/day) PDE5i were included in our study. Patients treated with Li-SWT and using PDE5i were classified as Group 1, patients treated with Li-SWT and using APs and using PDE5i were considered Group 2. The evaluation results of the International Index of Erectile Function-Erectile Function Area(IIEF-EF) in all patients baseline and after treatment were examined. Results: There are 25 patients in each group. Analysis of IIEF-EF scores showed significant increases in both groups after treatment [group 1 (p=0.001); group 2 (p=0.001)]. When the IIEF-EF scores of the groups before and after the treatment were compared with each other; it was shown that baseline scores were similar(p=0.746) and that APs use had no statistically significant effect on post-treatment scores (p=0.613) No side effects were seen in APs. Conclusions: This study showed that penile Li-SWT significantly increases the IIEF-EF scores and response of (5 mg/day) PDE5i in ED patients and safe, also in AP users. However, Using AP in Li- SWT does not contribute positively to clinical results.
dc.identifier.doi	10.36516/jocass.1247105
dc.identifier.endpage	198	en_US
dc.identifier.issn	2667-498X
dc.identifier.issue	2	en_US
dc.identifier.startpage	194	en_US
dc.identifier.uri	https:/dx.doi.org 10.36516/jocass.1247105
dc.identifier.uri	https://hdl.handle.net/20.500.12451/11492
dc.identifier.volume	6	en_US
dc.indekslendigikaynak	TR-Dizin
dc.language.iso	en
dc.publisher	Merthan TUNAY
dc.relation.ispartof	Çukurova Anestezi ve Cerrahi Bilimler Dergisi
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	Erectile Dysfunction (ED)
dc.subject	Antiplatelet (AP)
dc.subject	Endothelial Dysfunction
dc.subject	Low Intensity Extracorporeal Shockwave Therapy (Li-SWT)
dc.subject	Phosphodiesterase Type 5 Inhibitor (PDE5i)
dc.title	Do Antiplatelet Drugs Use Contribute to Clinical Outcomes in Patients Receiving Penile Low- Intensity Shock Wave Therapy (Li-SWT) for Erectile Dysfunction?
dc.type	Other